AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+1.4%
5Y CAGR+12.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+1.4%/yr
vs +24.8%/yr prior
5Y CAGR
+12.0%/yr
Recent deceleration
Acceleration
-23.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.92B | +11.1% |
| 2024 | $15.22B | +4.8% |
| 2023 | $14.53B | -10.6% |
| 2022 | $16.25B | +6.6% |
| 2021 | $15.24B | +58.5% |
| 2020 | $9.62B | +10.7% |
| 2019 | $8.68B | +29.7% |
| 2018 | $6.70B | +22.8% |
| 2017 | $5.45B | +31.6% |
| 2016 | $4.14B | - |